Trinity Biosystems
Latest round
- Series B
Last raised
- Jul 2006
Total raised
- $23M
Investors
- 4
About Trinity Biosystems
Founded in 2002, Trinity Biosystems, Inc. engages in the development and formulation of oral therapeutic proteins. It involves in developing vaccines in the areas of respiratory, digestive, and sexually transmitted diseases.
Who invested in Trinity Biosystems
4 investors across 2 rounds
See all investors in Trinity Biosystems
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Trinity Biosystems
Who invested in Trinity Biosystems?
Trinity Biosystems has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Trinity Biosystems raised?
Trinity Biosystems has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Trinity Biosystems last raise money?
Trinity Biosystems's most recent round on record is a Series B, in Jul 2006.
What does Trinity Biosystems do?
Founded in 2002, Trinity Biosystems, Inc.
Where is Trinity Biosystems headquartered?
Trinity Biosystems is headquartered in Menlo Park, US.
Which VCs invest in companies like Trinity Biosystems?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Trinity Biosystems's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Trinity Biosystems? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.